Medigen Biotechnology Market Cap

Medigen Biotechnology has a market cap or net worth of 4.14 billion as of May 6, 2025. Its market cap has decreased by -23.97% in one year.

Market Cap

4.14B

Enterprise Value

6.02B

Revenue

1.37B

Ranking

n/a

PE Ratio

n/a

Stock Price

29.70

Market Cap Chart

Since November 3, 2004, Medigen Biotechnology's market cap has increased from 684.56M to 4.14B, an increase of 504.39%. That is a compound annual growth rate of 9.17%.

Market Cap History

Date	Market Cap	% Change
May 5, 2025	4.07B	-9.88%
Dec 31, 2024	4.51B	-27.70%
Dec 29, 2023	6.24B	33.24%
Dec 30, 2022	4.69B	-41.43%
Dec 30, 2021	8.00B	-2.78%
Dec 31, 2020	8.23B	-4.46%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	179.18B
Caliway Biopharmaceuticals	109.31B
Bora Pharmaceuticals Co., LTD.	73.94B
Lotus Pharmaceutical	59.64B
Oneness Biotech	29.21B
Polaris Group	28.42B
Lumosa Therapeutics	28.12B
Pegavision	27.14B

Market Cap Rankings